Gastroenterology

Filter

Retracted: Ozanimod▼ in Ulcerative Colitis: Key New Data

February 2025

This article has now been retracted and a retraction statement has been published.

Nutritional Management of Paediatric Crohn’s Disease

For many people with Crohn’s disease (CD), onset occurs in childhood or adolescence. Treatment for CD has moved from predominantly surgical to…

Early Intervention with Anti-Tumour Necrosis Factor in Ulcerative Colitis: The Missing Piece of The Puzzle?

In an interactive symposium moderated by Dr Cummings, the question: “Is early intervention with anti-TNF the key to achieving long-lasting remission…

The Illusion of Remission

Dr Raine described corticosteroids as the first IBD drugs to undergo clinical trials. A seminal study, one of the first to introduce the concept…

20 20 Vision in IBD

Over the past years, the conceptual framework behind the pathogenesis of IBD has come into sharper focus. In healthy individuals, the intestinal…

New dimensions: exploring recent data and measures in IBD

UC is a chronic, progressive disorder with an unknown aetiology.1 Few population-based cohort studies have assessed both disease course and the use…

Medtronic cover image

Artificial Intelligence in Colonoscopy

CRC is the third most common form of cancer globally, with 1.8 million new cases diagnosed every year…

‘Old but Gold’ – Insights About Anti-TNF-α Therapy in the Treatment of Inflammatory Bowel Disease

Prof Panaccione believed that biologic therapies are generally underutilised in patients with IBD; they are started too late and prescribed to too few…

Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases

The treatment armamentarium is expanding for patients with UC and Crohn’s disease (CD). The treatments currently available include anti-inflammatory…

Loading posts...

« Previous 1 2 3 4 5 … 8 Next »